Holen Sie sich die Stockscreener-App
27.59
1.18%
-0.33
Handel nachbörslich:
27.59
Schlusskurs vom Vortag:
$27.92
Offen:
$27.8
24-Stunden-Volumen:
64,544
Relative Volume:
0.31
Marktkapitalisierung:
$394.47M
Einnahmen:
$138.20M
Nettoeinkommen (Verlust:
$5.52M
KGV:
72.61
EPS:
0.38
Netto-Cashflow:
$9.86M
1W Leistung:
-4.27%
1M Leistung:
-13.67%
6M Leistung:
-2.99%
1J Leistung:
-28.00%
1-Tages-Spanne:
$27.30
$27.95
1-Wochen-Bereich:
$27.30
$29.00
52-Wochen-Spanne:
$26.00
$40.38
Surmodics Inc Stock (SRDX) Company Profile
Firmenname
Surmodics Inc
Sektor
Branche
Telefon
(952) 500-7000
Adresse
9924 W 74TH ST, EDEN PRAIRIE, MN
Vergleichen Sie SRDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
27.59 | 399.19M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
133.27 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
370.00 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.54 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.36 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-07 | Hochstufung | Lake Street | Hold → Buy |
| 2023-06-13 | Hochstufung | Needham | Hold → Buy |
| 2023-02-13 | Herabstufung | Needham | Buy → Hold |
| 2020-07-23 | Hochstufung | Needham | Hold → Buy |
| 2019-12-11 | Herabstufung | Needham | Buy → Hold |
| 2019-11-01 | Herabstufung | Lake Street | Buy → Hold |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Lake Street | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-02-21 | Bestätigt | Needham | Buy |
| 2018-05-16 | Bestätigt | Needham | Buy |
| 2018-03-01 | Hochstufung | Sidoti | Neutral → Buy |
| 2018-02-28 | Bestätigt | Lake Street | Buy |
| 2018-02-28 | Eingeleitet | Needham | Buy |
| 2017-07-14 | Eingeleitet | Lake Street | Buy |
| 2016-11-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-10-06 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-05-03 | Bestätigt | Barrington Research | Outperform |
| 2015-08-06 | Bestätigt | Barrington Research | Outperform |
| 2015-03-27 | Eingeleitet | Dougherty & Company | Buy |
| 2014-02-25 | Eingeleitet | Laidlaw | Buy |
| 2013-08-01 | Hochstufung | Feltl & Co. | Buy → Strong Buy |
| 2012-11-12 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Surmodics Inc Aktie (SRDX) Neueste Nachrichten
Surmodics unveils Pounce LP Thrombectomy System innovation - Traders Union
How institutional ownership impacts Surmodics Inc. stockWeekly Profit Report & Daily Chart Pattern Signals - newser.com
Published on: 2025-10-14 01:12:14 - newser.com
Does Surmodics Inc. fit your quant trading model2025 Big Picture & Safe Entry Momentum Tips - newser.com
Will breakout in Surmodics Inc. lead to full recoveryWeekly Trade Report & Community Verified Trade Alerts - newser.com
Will Surmodics Inc. stock return to pre crisis levels2025 Retail Activity & Free Daily Entry Point Trade Alerts - newser.com
Is Surmodics Inc. stock resilient to inflationQuarterly Trade Report & Daily Stock Trend Reports - newser.com
Published on: 2025-10-13 08:05:24 - newser.com
Applying big data sentiment scoring on Surmodics Inc.2025 Price Targets & Verified Chart Pattern Trade Signals - newser.com
Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenges With A Focus On Innovation - DirectorsTalk Interviews
How moving averages guide Surmodics Inc. trading2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com
What MACD signals say about Surmodics Inc.July 2025 Review & Weekly High Potential Alerts - newser.com
Has Surmodics Inc. formed a bullish divergence2025 Support & Resistance & Daily Oversold Bounce Ideas - newser.com
Surmodics (NASDAQ:SRDX) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Measuring Surmodics Inc.’s beta against major indicesBull Run & Reliable Volume Spike Trade Alerts - newser.com
Is Surmodics Inc. stock supported by strong cash flowsQuarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
Surmodics Inc Stock Analysis and ForecastGrowth vs. Value Investing & High Yield Trading Alerts - earlytimes.in
Statistical indicators supporting Surmodics Inc.’s strengthWeekly Volume Report & Fast Gain Swing Alerts - newser.com
Risk vs reward if holding onto Surmodics Inc.July 2025 Levels & Verified Chart Pattern Signals - newser.com
Multi factor analysis applied to Surmodics Inc.Quarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Surmodics, Inc. (NASDAQ:SRDX) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Short interest data insights for Surmodics Inc.Entry Point & Short-Term Trading Opportunity Alerts - newser.com
Is Surmodics Inc. stock a buy for dividend growthAnalyst Upgrade & Free Real-Time Market Sentiment Alerts - newser.com
How to monitor Surmodics Inc. with trend dashboards2025 Short Interest & Reliable Price Action Trade Plans - newser.com
Published on: 2025-10-02 22:35:48 - newser.com
Is Surmodics Inc. forming a reversal patternTrade Performance Summary & Verified Momentum Stock Alerts - newser.com
US FTC delays GTCR-Surmodics evidentiary hearing until Feb. 2, 2026 - MLex
Finanzdaten der Surmodics Inc-Aktie (SRDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Surmodics Inc-Aktie (SRDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| DANTZKER DAVID | Director |
Feb 13 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
44,399 |
| BEDOYA JOSE H | Director |
Feb 14 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
34,232 |
| KNIGHT SUSAN E | Director |
Jan 24 '25 |
Option Exercise |
27.30 |
7,358 |
200,873 |
42,506 |
| Arens Timothy J. | Chief Financial Officer |
Nov 26 '24 |
Sale |
39.44 |
7,009 |
276,453 |
70,350 |
1.19%
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):